Streptococcus pneumoniae Serotype 1 Capsular Polysaccharide Induces CD8+CD28- Regulatory T Lymphocytes by TCR Crosslinking

被引:16
|
作者
Mertens, Janina [1 ]
Fabri, Mario [1 ]
Zingarelli, Alessandra [1 ]
Kubacki, Torsten [1 ]
Meemboor, Sonja [1 ]
Groneck, Laura [1 ]
Seeger, Jens [1 ]
Bessler, Martina [1 ]
Hafke, Helena [1 ]
Odenthal, Margarete [2 ]
Bieler, Joan G. [5 ]
Kalka, Christoph [3 ,4 ]
Schneck, Jonathan P. [5 ]
Kashkar, Hamid [1 ]
Kalka-Moll, Wiltrud M. [1 ]
机构
[1] Univ Cologne, Med Ctr, Inst Med Microbiol Immunol & Hyg, Cologne, Germany
[2] Univ Cologne, Med Ctr, Dept Pathol, Cologne, Germany
[3] Univ Hosp Bern, Inselspital, Div Vasc Med, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland
[4] Univ Bern, CH-3010 Bern, Switzerland
[5] Johns Hopkins Sch Med, Div Immunopathol, Dept Pathol, Baltimore, MD USA
关键词
PLASMACYTOID DENDRITIC CELLS; MYELIN BASIC-PROTEIN; GROWTH-FACTOR-BETA; MOUSE BONE-MARROW; IMMUNE-RESPONSES; ZWITTERIONIC POLYSACCHARIDES; AUTOIMMUNE-DISEASE; ABSCESS FORMATION; IN-VIVO; INTRAABDOMINAL INFECTIONS;
D O I
10.1371/journal.ppat.1000596
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Zwitterionic capsular polysaccharides (ZPS) of commensal bacteria are characterized by having both positive and negative charged substituents on each repeating unit of a highly repetitive structure that has an alpha-helix configuration. In this paper we look at the immune response of CD8(+) T cells to ZPSs. Intraperitoneal application of the ZPS Sp1 from Streptococcus pneumoniae serotype 1 induces CD8(+)CD28(-) T cells in the spleen and peritoneal cavity of WT mice. However, chemically modified Sp1 (mSp1) without the positive charge and resembling common negatively charged polysaccharides fails to induce CD8(+)CD28(-) T lymphocytes. The Sp1-induced CD8(+)CD28(-) T lymphocytes are CD122(low)CTLA-4(+)CD39(+). They synthesize IL-10 and TGF-beta. The Sp1-induced CD8(+)CD28(-) T cells exhibit immunosuppressive properties on CD4(+) T cells in vivo and in vitro. Experimental approaches to elucidate the mechanism of CD8+ T cell activation by Sp1 demonstrate in a dimeric MHC class I-Ig model that Sp1 induces CD8(+) T cell activation by enhancing crosslinking of TCR. The expansion of CD8(+)CD28(-) T cells is independent, of direct antigen-presenting cell/T cell contact and, to the specificity of the T cell receptor (TCR). In CD8(+)CD28(-) T cells, Sp1 enhances Zap-70 phosphorylation and increasingly involves NF-kappa B which ultimately results in protection versus apoptosis and cell death and promotes survival and accumulation of the CD8(+)CD28(-) population. This is the first description of a naturally occurring bacterial antigen that is able to induce suppressive CD8(+)CD28(-) T lymphocytes in vivo and in vitro. The underlying mechanism of CD8(+) T cell activation appears to rely on enhanced TCR crosslinking. The data provides evidence that ZPS of commensal bacteria play an important role in peripheral tolerance mechanisms and the maintenance of the homeostasis of the immune system.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] TCR repertoire of suppressor CD8+CD28- T cell populations
    Pennesi, G
    Liu, ZR
    Ciubotariu, R
    Jiang, SP
    Colovai, A
    Cortesini, R
    Suciu-Foca, N
    Harris, P
    [J]. HUMAN IMMUNOLOGY, 1999, 60 (04) : 291 - 304
  • [2] CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice
    Menager-Marcq, Ingrid
    Pomie, Celine
    Romagnoli, Paola
    van Meerwijk, Joost P. M.
    [J]. GASTROENTEROLOGY, 2006, 131 (06) : 1775 - 1785
  • [3] Balance of CD8+CD28+/CD8+CD28- T Lymphocytes Is Vital for Patients with Ulcerative Colitis
    Dai, Shi-Xue
    Wu, Gang
    Zou, Ying
    Feng, Yan-Ling
    Liu, Hong-Bo
    Feng, Jin-Shan
    Chi, Hong-Gang
    Lv, Ru-Xi
    Zheng, Xue-Bao
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (01) : 88 - 96
  • [4] Temporal kinetics of CD8+CD28+ and CD8+CD28- T lymphocytes in the injured rat spinal cord
    Wu, Yan
    Lin, Yu-Hong
    Shi, Ling-Ling
    Yao, Zong-Feng
    Xie, Xiu-Mei
    Jiang, Zheng-Song
    Tang, Jie
    Hu, Jian-Guo
    Lu, He-Zuo
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2017, 95 (08) : 1666 - 1676
  • [5] Regulatory functions of CD8+CD28- T cells in an autoimmune disease model
    Najafian, N
    Chitnis, T
    Salama, AD
    Zhu, B
    Benou, C
    Yuan, XL
    Clarkson, MR
    Sayegh, MH
    Khoury, SJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07): : 1037 - 1048
  • [6] CD8+CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers
    Filaci, Gilberto
    Fenoglio, Daniela
    Fravega, Marco
    Ansaldo, Gianluca
    Borgonovo, Giacomo
    Traverso, Paolo
    Villaggio, Barbara
    Ferrera, Alessandra
    Kunkl, Annalisa
    Rizzi, Marta
    Ferrera, Francesca
    Balestra, Piercesare
    Ghio, Massimo
    Contini, Paola
    Setti, Maurizio
    Olive, Daniel
    Azzarone, Bruno
    Carmignani, Giorgio
    Ravetti, Jean Louis
    Torre, Giancarlo
    Indiveri, Francesco
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 179 (07): : 4323 - 4334
  • [7] Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28- T-cells
    Neuber, Brigitte
    Dai, Jingying
    Waraich, Wjahat A.
    Awwad, Mohamed H. S.
    Engelhardt, Melanie
    Schmitt, Michael
    Medenhoff, Sergej
    Witzens-Harig, Mathias
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Hundemer, Michael
    [J]. ONCOTARGET, 2017, 8 (58) : 98200 - 98214
  • [8] Proliferation and apoptosis of human CD8+CD28+ and CD8+CD28- lymphocytes during aging
    Brzezinska, A
    Magalska, A
    Szybinska, A
    Sikora, E
    [J]. EXPERIMENTAL GERONTOLOGY, 2004, 39 (04) : 539 - 544
  • [9] Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease
    Ceeraz, Sabrina
    Thompson, Charlotte R.
    Beatson, Richard
    Choy, Ernest H.
    [J]. CELLS, 2021, 10 (11)
  • [10] Increased Percentage of CD8+CD28- Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis
    Houston, Timothy W.
    Howlett-Prieto, Quentin
    Regenauer, Colin
    Testai, Fernando D.
    Yao, Faith
    Feng, Xuan
    Reder, Anthony T.
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (02):